CD274 and neoplasm: In this study, most patients underwent a combination of treatments, including repeat liver resection, ablation, TACE, targeted therapy and immunotherapy with PD‐1/PD‐L1 inhibitors, more frequently after tumor recurrence, all of which may have affected the final survival outcomes observed in our study.